| Interferons: present and future use in cancer therapy |
| HM Golomb |
|
JCO Feb 1 1986: 123–125.
[PDF]
|
 |
| AIDS-related lymphadenopathy: the role of biopsy |
| DI Abrams |
|
JCO Feb 1 1986: 126–127.
[PDF]
|
|
|
Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study |
| |
MJ O'Connell, JP Colgan, MM Oken, RE Ritts, Jr, NE Kay, and LM Itri |
| |
JCO Feb 1 1986: 128–136.
[Abstract]
[PDF]
|
|
|
Phase I trial of recombinant interferon gamma in cancer patients |
| |
S Vadhan-Raj, A Al-Katib, R Bhalla, L Pelus, CF Nathan, SA Sherwin, HF Oettgen, and SE Krown |
| |
JCO Feb 1 1986: 137–146.
[Abstract]
[PDF]
|
|
|
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80) |
| |
B Coiffier, PA Bryon, F Berger, E Archimbaud, M Ffrench, JM Extra, D Guyotat, D Fiere, O Gentilhomme, and JP Magaud |
| |
JCO Feb 1 1986: 147–153.
[Abstract]
[PDF]
|
|
|
Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study |
| |
NJ Bunin, E Hvizdala, M Link, TR Callihan, HO Hustu, M Wharam, RA Warnke, CW Berard, and SB Murphy |
| |
JCO Feb 1 1986: 154–159.
[Abstract]
[PDF]
|
|
|
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions |
| |
JO Armitage, DD Weisenburger, M Hutchins, DF Moravec, M Dowling, S Sorensen, J Mailliard, J Okerbloom, PS Johnson, and D Howe |
| |
JCO Feb 1 1986: 160–164.
[Abstract]
[PDF]
|
|
|
Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy |
| |
AM Levine, PR Meyer, PS Gill, RL Burkes, M Krailo, S Aguilar, and JW Parker |
| |
JCO Feb 1 1986: 165–169.
[Abstract]
[PDF]
|
|
|
Clinicopathologic aspects of E rosette negative T cell acute lymphocytic leukemia: a Pediatric Oncology Group study |
| |
MJ Borowitz, BL Dowell, JM Boyett, DJ Pullen, WM Crist, FM Quddus, JM Falletta, and RS Metzgar |
| |
JCO Feb 1 1986: 170–177.
[Abstract]
[PDF]
|
|
|
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer |
| |
JN Ingle, JE Krook, SJ Green, TP Kubista, LK Everson, DL Ahmann, MN Chang, HF Bisel, HE Windschitl, and DI Twito |
| |
JCO Feb 1 1986: 178–185.
[Abstract]
[PDF]
|
|
|
A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia |
| |
|
| |
JCO Feb 1 1986: 186–193.
[Abstract]
[PDF]
|
|
|
High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy |
| |
CR Pinkerton, J Pritchard, and L Spitz |
| |
JCO Feb 1 1986: 194–199.
[Abstract]
[PDF]
|
|
|
Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer |
| |
BJ Brooks, Jr, EJ Seifter, TE Walsh, AS Lichter, PA Bunn, A Zabell, A Johnston- Early, M Edison, RW Makuch, and MH Cohen |
| |
JCO Feb 1 1986: 200–209.
[Abstract]
[PDF]
|
|
|
Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion |
| |
S Korec, PS Schein, FP Smith, JR Neefe, PV Woolley, RM Goldberg, and TM Phillips |
| |
JCO Feb 1 1986: 210–215.
[Abstract]
[PDF]
|
|
|
Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients |
| |
JE Karp and WG Merz |
| |
JCO Feb 1 1986: 216–220.
[Abstract]
[PDF]
|
|
|
Cataracts induced by intermittent Decadron used as an antiemetic |
| |
AZ Bluming and P Zeegen |
| |
JCO Feb 1 1986: 221–223.
[Abstract]
[PDF]
|
|
|
Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy |
| |
DR Nerenz, H Leventhal, DV Easterling, and RR Love |
| |
JCO Feb 1 1986: 224–233.
[Abstract]
[PDF]
|
|
|
Clinical toxicity of interferons in cancer patients: a review |
| |
JR Quesada, M Talpaz, A Rios, R Kurzrock, and JU Gutterman |
| |
JCO Feb 1 1986: 234–243.
[Abstract]
[PDF]
|
|
|
Tumor heterogeneity and drug resistance |
| |
DL Dexter and JT Leith |
| |
JCO Feb 1 1986: 244–257.
[Abstract]
[PDF]
|
|
| Interpretation of results of chemotherapy trials in metastatic breast cancer |
|
|
JCO Feb 1 1986: 258–261.
[PDF]
|
|
| Ethics in oncology textbooks |
| CM Haskell |
|
JCO Feb 1 1986: 261–262.
[PDF]
|
|
| Randomized trials in rare tumors |
| GA Omura |
|
JCO Feb 1 1986: 262–263.
[PDF]
|
|
| Antiemetic efficacy of dexamethasone |
| MS Aapro |
|
JCO Feb 1 1986: 263a.
[PDF]
|
|
| The problem of mixed cellularity lymphoma |
| MD Goodyear |
|
JCO Feb 1 1986: 263b–264.
[PDF]
|
|
|
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology |
| |
BJ Kennedy, P Calabresi, B Clarkson, and E Frenkel |
| |
JCO Feb 1 1986: 269–270.
[Abstract]
[PDF]
|
|
